Related references
Note: Only part of the references are listed.An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors
Aine O'Reilly et al.
SUPPORTIVE CARE IN CANCER (2020)
Neuronal autoantibodies associated with cognitive impairment in melanoma patients
F. Bartels et al.
ANNALS OF ONCOLOGY (2019)
Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma
Y. J. L. Jansen et al.
ANNALS OF ONCOLOGY (2019)
Certainty within uncertainty: a qualitative study of the experience of metastatic melanoma patients undergoing pembrolizumab immunotherapy
David Levy et al.
SUPPORTIVE CARE IN CANCER (2019)
Time to Study Metastatic-Cancer Survivorship
Terry Langbaum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Long-Term Survival, Quality of Life, and Psychosocial Outcomes in Advanced Melanoma Patients Treated with Immune Checkpoint Inhibitors
Anne Rogiers et al.
JOURNAL OF ONCOLOGY (2019)
The survivorship experience for patients with metastatic melanoma on immune checkpoint and BRAF-MEK inhibitors
Julia Lai-Kwon et al.
JOURNAL OF CANCER SURVIVORSHIP (2019)
Circulating epinephrine is not required for chronic stress to enhance metastasis
Adam K. Walker et al.
PSYCHONEUROENDOCRINOLOGY (2019)
Long-term quality of life profile in oncology: a comparison between cancer survivors and the general population
Maria Antonietta Annunziata et al.
SUPPORTIVE CARE IN CANCER (2018)
Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma
Caroline Robert et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Return to work in European Cancer survivors: a systematic review
Sara Paltrinieri et al.
SUPPORTIVE CARE IN CANCER (2018)
Post-Traumatic Stress Disorder
Arieh Shalev et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Review of systematic reviews of non-pharmacological interventions to improve quality of life in cancer survivors
Morvwen Duncan et al.
BMJ OPEN (2017)
CogState computerized memory tests in patients with brain metastases: secondary endpoint results of NRG Oncology RTOG 0933
Chip Caine et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
A systematic review examining factors influencing health related quality of life among melanoma cancer survivors
Jean-Francois Hamel et al.
EUROPEAN JOURNAL OF CANCER (2016)
Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanoma
Dirk Schadendorf et al.
EUROPEAN JOURNAL OF CANCER (2016)
Cancer in Europe: Death sentence or life sentence?
Lifang Liu et al.
EUROPEAN JOURNAL OF CANCER (2016)
Psychoeducational Intervention to Reduce Fear of Cancer Recurrence in People at High Risk of Developing Another Primary Melanoma: Results of a Randomized Controlled Trial
Mbathio Dieng et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Computerized Cognitive Training for Amelioration of Cognitive Late Effects Among Childhood Cancer Survivors: A Randomized Controlled Trial
Heather M. Conklin et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Depression, Anxiety and Quality of Life in Long-Term Survivors of Malignant Melanoma: A Register-Based Cohort Study
Manfred E. Beutel et al.
PLOS ONE (2015)
The nature and rate of cognitive maturation from late childhood to adulthood
Jason A. Cromer et al.
FRONTIERS IN PSYCHOLOGY (2015)
European reference values for the quality of life questionnaire EORTC QLQ-C30: Results of a German investigation and a summarizing analysis of six European general population normative studies
Andreas Hinz et al.
ACTA ONCOLOGICA (2014)
A validation study of the Hospital Anxiety and Depression Scale (HADS) in a large sample of French employees
Christin Bocran et al.
BMC PSYCHIATRY (2014)
A nervous tumor microenvironment: the impact of adrenergic stress on cancer cells, immunosuppression, and immunotherapeutic response
Jason W-L Eng et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Inflamed moods: A review of the interactions between inflammation and mood disorders
Joshua D. Rosenblat et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
So depression is an inflammatory disease, but where does the inflammation come from?
Michael Berk et al.
BMC MEDICINE (2013)
Validity of a Brief Computerized Cognitive Screening Test in Dementia
Dustin Hammers et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2012)
Fast screening of depression in cancer patients: the effectiveness of the HADS
L. Castelli et al.
EUROPEAN JOURNAL OF CANCER CARE (2011)
International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer
Jeffrey S. Wefel et al.
LANCET ONCOLOGY (2011)
Criterion and Construct Validity of the CogState Schizophrenia Battery in Japanese Patients with Schizophrenia
Taisuke Yoshida et al.
PLOS ONE (2011)
Measuring fatigue in patients with multiple sclerosis: reproducibility, responsiveness and concurrent validity of three Dutch self-report questionnaires
M. B. Rietberg et al.
DISABILITY AND REHABILITATION (2010)
Psychological Responses and Coping Strategies Among Patients With Malignant Melanoma A Systematic Review of the Literature
Nadine A. Kasparian et al.
ARCHIVES OF DERMATOLOGY (2009)
Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer
Andrew H. Miller et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Assessing cognitive function in cancer patients
Janette Vardy et al.
SUPPORTIVE CARE IN CANCER (2006)
A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer
P Stone et al.
ANNALS OF ONCOLOGY (2000)
Share Paper
